Latest Commercialisation News

Page 2 of 171
Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.
Ada Torres
Ada Torres
13 May 2026
5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.
Maxwell Dee
Maxwell Dee
13 May 2026
Archer Materials is progressing toward demonstrating a working qubit this year while scaling quantum device fabrication from lab prototypes to wafer-scale manufacturing using semiconductor industry standards.
Sophie Babbage
Sophie Babbage
12 May 2026
4DS Memory is accelerating commercialisation of its 60nm ReRAM technology in India, aligning with the country’s AUD$25 billion semiconductor investment and targeting mature-node industrial and defence sectors.
Sophie Babbage
Sophie Babbage
12 May 2026
Green360 Technologies has landed its first named commercial customer for Eco-Clay, signing a non-binding MOU with Holcim Australia to supply up to 4,800 tonnes over 12 months, marking a key step in commercialising its low-carbon cement replacement.
Maxwell Dee
Maxwell Dee
12 May 2026
Metallium has successfully completed a 12-hour continuous run of its commercial-scale Flash Joule Heating reactor, demonstrating stable operation and exceeding throughput expectations. This milestone reduces scale-up risks ahead of planned multi-reactor deployment at its Texas facility.
Maxwell Dee
Maxwell Dee
12 May 2026
Energy Transition Minerals has secured a non-binding MOU with Traxys Europe for the potential exclusive offtake of tin, tantalum, and niobium concentrates from its Penouta mine, positioning the project as a strategic Western source of critical minerals.
Maxwell Dee
Maxwell Dee
12 May 2026
Acrux Limited has raised $1.6 million through a discounted share placement, attracting strong demand and offering attaching options to investors. The funds will support Phase III trials for female testosterone and a co-development deal with an international partner.
Ada Torres
Ada Torres
11 May 2026
dorsaVi has secured a 12-month renewal of its Department of Defense-funded research with Georgia Southern University, advancing real-time gait optimisation to reduce military training injuries and laying groundwork for its exoskeleton and neuromorphic computing strategy.
Sophie Babbage
Sophie Babbage
11 May 2026
Pathkey.AI appoints Andrew Farnsworth as CEO, leveraging his defence and AI expertise to drive commercialisation of TrialKey and Chipforge platforms.
Sophie Babbage
Sophie Babbage
11 May 2026
Ionic Rare Earths’ subsidiary Ionic Technologies has led a pioneering UK project demonstrating a fully circular supply chain for electric vehicle magnets using 100% recycled rare earth oxides, achieving performance parity with primary materials and advancing UK critical minerals goals.
Maxwell Dee
Maxwell Dee
11 May 2026
Temas Resources’ 2026 re-assays of 2022 drill samples at La Blache reveal material uplifts in vanadium, gallium, scandium, and chromium grades, strengthening the case for its proprietary Regenerative Chloride Leach technology.
Maxwell Dee
Maxwell Dee
11 May 2026